ESR1 and cancer: Further AdnaTest allows the detection of different additional markers such as ER, PR and EMT- or CSC-markers [50, 51] offering the possibility to further characterize the biology and molecular abnormalities of CTC to better understand the metastasizing process as well as to conduct personalized CTC directed cancer treatment [9].